South America Vaccines Market Outlook, 2028

South America Vaccines Market Outlook, 2028

In South America, there is a growing emphasis on preventive healthcare, and vaccines are considered a crucial component of this approach. Governments and healthcare authorities prioritise vaccination programmes to protect public health and prevent the spread of infectious diseases. Many South American countries have established robust government-led immunisation programs. These programmes aim to provide free or subsidised vaccines to a large portion of the population, particularly children, pregnant women, and vulnerable groups. South America has faced outbreaks of diseases like yellow fever, dengue, and measles in the past. These experiences have contributed to a strong awareness of the importance of vaccines in preventing epidemics and protecting communities. South America is culturally diverse, with various indigenous communities and distinct cultural practices. Tailoring vaccine education and delivery to respect cultural beliefs and traditions is important for ensuring widespread acceptance and uptake. Trust in healthcare professionals, including doctors and nurses, plays a significant role in vaccine acceptance. Establishing trust and open communication between healthcare providers and communities is vital for successful vaccination campaigns. South American countries often engage in community-based outreach efforts to promote vaccination. These initiatives involve local leaders, community health workers, and educational campaigns to raise awareness about the benefits of immunization. In addition to government-led efforts, the private sector, including clinics and pharmacies, also plays a role in vaccine distribution. This can provide additional access points for vaccinations, especially for those seeking specific vaccines or booster shots. South American countries often collaborate with international organisations and alliances, such as PAHO (Pan American Health Organisation), WHO (World Health Organisation), and UNICEF, to enhance access to vaccines and strengthen immunisation programmes.

According to the research report, ""South America Vaccines Market Outlook, 2028,"" published by Bonafide Research, the South America Vaccines market is anticipated to add more than USD 2.30 Billion to the market size from 2023 to 2028. The prevalence of vaccine-preventable diseases in South America is a significant driver of vaccine demand. Diseases such as influenza, measles, mumps, rubella, hepatitis, and others continue to pose health threats, making vaccines essential for disease control and prevention. Most South American countries have government-led immunisation programmes that provide free or subsidised vaccines to the population. These programmes often target specific age groups, such as infants, children, adolescents, and the elderly, contributing to the demand for vaccines. Efforts to improve healthcare access and infrastructure have expanded the reach of vaccination services in South America. This has made vaccines more accessible to rural and underserved populations, increasing demand. South American countries are vigilant about epidemic preparedness, given the risk of outbreaks such as dengue, Zika, and yellow fever. Vaccines play a crucial role in containing and preventing the spread of these diseases, leading to increased demand during outbreaks. Economic growth in some South American countries has led to increased healthcare spending, including investments in vaccination programs. As disposable incomes rise, more individuals can afford to pay for vaccines in the private sector. The presence of both domestic and international pharmaceutical companies in South America contributes to the development, production, and distribution of vaccines. This industry's efforts bolster the vaccine supply and meet demand.

Brazil has historically been a significant player in the global vaccine market. Brazil is the most populous country in South America. Its large population creates a substantial demand for vaccines to prevent and control various diseases. The Brazilian government has historically shown a strong commitment to public health and immunization. Brazil has a well-established National Immunisation Programme (PNI), which aims to provide free vaccines to the entire population. This programme is one of the largest and most comprehensive in the world. Brazil has a robust domestic vaccine production industry, with several state-owned and private vaccine manufacturers. The country has the capacity to produce a wide range of vaccines, including those for diseases like dengue, yellow fever, and influenza. This domestic production capability reduces dependence on imported vaccines and contributes to Brazil's leadership in the market. The country has faced several outbreaks of infectious diseases, such as the Zika virus, dengue fever, and yellow fever. These experiences have led to a strong focus on epidemic preparedness and vaccination campaigns, further driving the demand for vaccines. Brazil is a popular destination for international travellers and tourists. As a result, there is demand for travel vaccines, such as those for yellow fever, contributing to Brazil's prominence in the vaccine market.

Based on the technology types, they include conjugated vaccines, inactivated and subunit vaccines, live-attenuated vaccines, recombinant vaccines, and toxoid vaccines. In South America, live-attenuated vaccines have the second-highest market share. Live-attenuated vaccines are often highly effective at generating robust and long-lasting immunity. This is particularly important in South America, where various vaccine-preventable diseases, including measles, mumps, rubella, yellow fever, and rotavirus, are still significant public health concerns. Live-attenuated vaccines provide effective protection against these diseases. South America has experienced outbreaks of several infectious diseases in the past. These outbreaks have highlighted the importance of vaccination in disease prevention and control. Live-attenuated vaccines, such as the MMR (measles, mumps, and rubella) vaccine and the yellow fever vaccine, are crucial tools for managing and preventing such outbreaks. Public health campaigns and educational efforts promote the importance of vaccination and encourage parents to ensure their children receive recommended vaccines. This awareness has contributed to the acceptance and demand for live-attenuated vaccines.

In terms of the route of administration, it includes intramuscular and subcutaneous administration, oral administration, and others. In the region, the Oral Administration is growing. Oral vaccines offer a convenient and non-invasive method of immunization. This accessibility is particularly beneficial in rural and underserved areas of South America, where access to healthcare facilities and trained healthcare personnel may be limited. The ease of oral administration can help reach remote populations, improving vaccine coverage. Many vaccines administered via the oral route are designed for infants and young children. The paediatric population is a priority for vaccination in South America, and oral vaccines, such as those for rotavirus and polio, are essential tools for reducing child mortality and morbidity. South America faces various infectious diseases that can be effectively prevented by oral vaccines. For example, rotavirus is a leading cause of severe diarrhoea in children in the region, making the oral rotavirus vaccine a critical intervention. Public health campaigns and educational efforts emphasise the benefits of oral vaccination, increasing public awareness and acceptance of these vaccines.

According to the report, the end user is segmented into paediatric vaccines and adult accines. In South America, paediatric vaccines are the leading market. South American countries, like many other regions of the world, prioritise childhood immunisation as a fundamental component of public health. Ensuring that children receive essential vaccines is a cornerstone of disease prevention and control efforts. South America continues to face a high burden of vaccine-preventable diseases that disproportionately affect children. These diseases include measles, mumps, rubella, polio, hepatitis, rotavirus, and pneumococcal infections. Vaccination is particularly critical for reducing the morbidity and mortality associated with these diseases. South America has experienced outbreaks of vaccine-preventable diseases in the past. These outbreaks, often linked to low vaccination coverage, highlight the importance of vaccinating children to prevent the spread of diseases in the community. South American countries typically have well-structured, government-led immunisation programmes that target children. These programmes offer free or subsidised vaccines to ensure broad coverage in this age group.

Dieses is segmented into the rotavirus, pneumococcal diseases, cancer, influenza, diphtheria, pertussis, and tetanus (DTP), human papilloma virus (HPV), hepatitis, shingles, meningococcal diseases, varicella (chicken pox), mumps, and others (dengue, typhoid, polio, Japanese encephalitis, rubella, herpes zoster, tuberculosis, and yellow fever). In South America, the Human Papilloma Virus (HPV) will grow at the highest rate. Many South American governments recognise the importance of preventing cervical cancer and have included the HPV vaccine in their national immunisation programs. This commitment to providing the vaccine for free or at a subsidised cost increases access and drives demand. HPV vaccination is generally well-accepted by communities in South America. The emphasis on preventing a potentially deadly disease like cervical cancer makes the vaccine an attractive preventive healthcare option. Some countries in South America have expanded HPV vaccination recommendations to include both boys and girls. This gender-neutral approach aims to reduce HPV transmission and protect against a broader range of associated cancers.

Based on types segmented into multivalent vaccines and monovalent vaccines, in the region, multivalent vaccines are more preferred by South American people. Multivalent vaccines are often used in paediatric vaccination programs. South American countries prioritise the health of children and infants, making these vaccines a key component of childhood immunisation schedules. Examples include combination vaccines like the pentavalent vaccine, which protects against diphtheria, tetanus, pertussis, hepatitis B, and Haemophilus influenza type B (Hib). Multivalent vaccines enhance immunisation coverage rates. Simplifying the vaccination process by reducing the number of shots required can increase the likelihood that individuals receive all recommended vaccines, including those for less common diseases. Distribution channels include hospital pharmacy, retail pharmacy, institutional sales, and others; among them, hospital pharmacy is the leading market. Hospital pharmacies are an integral part of the healthcare infrastructure in South America. They are well-equipped to handle and store vaccines at the required temperature conditions, ensuring the integrity and safety of the vaccines. Hospitals have trained healthcare professionals, including pharmacists and nurses, who are skilled in vaccine administration and patient counseling. This expertise is crucial for the proper administration and monitoring of vaccines, particularly for certain high-risk populations or specialised vaccines.
 
Companies Covered in this report:

Merck & Co. Inc, GlaxoSmithKline PLC, CSL, Charles River Laboratories, Daiichi Sankto Company Ltd, Sanofi S.A, AstraZeneca plc, Pfizer Inc, Takeda Pharmaceutical Company Limited.

Considered in this report:

• Geography: South America
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report:

• South America Vaccines market Outlook with its value and forecast along with its segments
• Country-wise Transformers market analysis
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

Country Covered in this report:

• Brazil
• Argentina
• Colombia

By Technology

• Conjugate vaccines
• Inactivated & Subunit vaccines
• Live Attenuated vaccines
• Recombinant vaccines
• Toxoid vaccines
• Viral vector vaccines
• Others

By Route of Administration

• Intramuscular and subcutaneous administration
• Oral administration
• Others

By End-User Type

• Paediatrics
• Adults

By Disease

• Pneumococcal diseases
• Cancer
• Influenza
• Rotavirus
• Diphtheria, Pertussis, and Tetanus (DTP)
• Human Papilloma Virus (HPV)
• Shingles
• Meningococcal diseases
• Hepatitis
• Varicella (Chicken Pox)
• Mumps
• Others

By Type

• Monovalent vaccines
• Multivalent vaccines

By Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others

The approach of the report:

This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and list out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, and annual reports of companies, analyzing the government-generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers into regional aspects, tier aspects, age groups, and gender. Once we have primary data with us we started verifying the details obtained from secondary sources.

Intended audience:

This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to the Drone industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.

***Please Note:It will take 48 hours (2 Business days) for delivery of the report upon order confirmation.